David A. Burns
Chief Executive Officer at Cellectricon AB
Profile
David A.
Burns currently works at Cellectricon AB, as Chief Executive Officer & Director from 2011.
Mr. Burns also formerly worked at Hammersmith Imanet Ltd., as Chief Executive Officer, GE Healthcare Niagara, Inc., as Chief Executive Officer, Renishaw Diagnostics Ltd., as Chief Executive Officer, Isogenica Ltd., as Non-executive Director, Packard BioScience Co., as Principal, Cyntellect, Inc., as Chief Operating Officer & VP-Sales & Marketing from 2008 to 2010, Pharmacia LKB Biotechnology, Inc., as Principal, PerkinElmer BioSignal, Inc., as Vice President-Business Development & Marketing, and GE UK Group, as Head-Strategic Growth & VP-Commercial Alliances.
Mr. Burns received his undergraduate degree from Napier University.
David A. Burns active positions
| Companies | Position | Start |
|---|---|---|
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Chief Executive Officer | 2011-09-20 |
Former positions of David A. Burns
| Companies | Position | End |
|---|---|---|
Packard BioScience Co.
 Packard BioScience Co. Medical SpecialtiesHealth Technology On July 13, 2001, the company entered into a merger agreement with PerkinElmer, Inc. Pursuant to the merger agreement, the company will become a subsidiary of PerkinElmer and each outstanding share of the company's common stock will be converted into 0.311 of a share of PerkinElmer common stock | Corporate Officer/Principal | - |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Director/Board Member | - |
PerkinElmer BioSignal, Inc.
 PerkinElmer BioSignal, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., PerkinElmer BioSignal, Inc. develops and markets cloned drug targets as drug screening reagents. The company is based in Montréal, Canada. | Sales & Marketing | - |
| GE Healthcare Niagara, Inc. | Chief Executive Officer | - |
Renishaw Diagnostics Ltd.
 Renishaw Diagnostics Ltd. Medical SpecialtiesHealth Technology Renishaw Diagnostics Ltd. provides diagnostic services to detect infectious diseases. The company is headquartered in Edinburgh, the United Kingdom. | Chief Executive Officer | - |
Training of David A. Burns
| Napier University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Packard BioScience Co.
Packard BioScience Co. Medical SpecialtiesHealth Technology On July 13, 2001, the company entered into a merger agreement with PerkinElmer, Inc. Pursuant to the merger agreement, the company will become a subsidiary of PerkinElmer and each outstanding share of the company's common stock will be converted into 0.311 of a share of PerkinElmer common stock | Health Technology |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |
Cyntellect, Inc.
 Cyntellect, Inc. Miscellaneous Commercial ServicesCommercial Services Cyntellect, Inc. develops life science technologies. Its products supported key applications to advance life science research, biopharmaceutical production, and stem cell research and drug discovery. The company was founded by Paul R. Billings, Manfred R. Koller and Bernhard O. Palsson in 1997 and was headquartered in San Diego, CA. | Commercial Services |
| Hammersmith Imanet Ltd. | |
| Pharmacia LKB Biotechnology, Inc. | |
PerkinElmer BioSignal, Inc.
PerkinElmer BioSignal, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., PerkinElmer BioSignal, Inc. develops and markets cloned drug targets as drug screening reagents. The company is based in Montréal, Canada. | Commercial Services |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
GE UK Group
 GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous |
| GE Healthcare Niagara, Inc. | |
Renishaw Diagnostics Ltd.
Renishaw Diagnostics Ltd. Medical SpecialtiesHealth Technology Renishaw Diagnostics Ltd. provides diagnostic services to detect infectious diseases. The company is headquartered in Edinburgh, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- David A. Burns
